Summary

Genetic testing that helps doctors select the right antidepressant for a patient did not lead to better improvements in depressive symptoms than standard prescriptions based on clinical guidelines, according to a clinical trial in Australia conducted by an international team of researchers. Led by professor Jonathan Emery of NTU's Lee Kong Chian School of Medicine and published in The Lancet Primary Care , the study challenges previous findings that using a patient's genetic information to personalize antidepressant treatment leads to better outcomes.

AI summaries can be wrong sometimes—always verify important details using the source article.